8 insiders reported 154 Form 4 transactions for Fulgent Genetics, Inc. (FLGT) over the past 18 months (most recent 2026-06-03). Recent activity: Hsieh Ming (Chief Executive Officer) Sell 4,392 shares, Gao Hanlin (Chief Scientific Officer) Sell 1,688 shares, Xie Jian (President and COO) Sell 2,146 shares, Kim Paul (CFO and Treasurer) Sell 2,087 shares, Nohaile Michael (Director) Buy 5,558 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | Hsieh Ming | Chief Executive Officer | Sell | 4,392 | $79,451 |
| 2026-06-03 | Gao Hanlin | Chief Scientific Officer | Sell | 1,688 | $30,191 |
| 2026-06-03 | Xie Jian | President and COO | Sell | 2,146 | $38,382 |
| 2026-06-03 | Kim Paul | CFO and Treasurer | Sell | 2,087 | $37,754 |
| 2026-05-18 | Nohaile Michael | Director | Buy | 5,558 | $0 |
| 2026-05-18 | GROVES REGINA E | Director | Buy | 11,117 | $0 |
| 2026-05-18 | Dong Linda | Director | Buy | 11,117 | $0 |
| 2026-04-28 | Kim Paul | CFO and Treasurer | Sell | 2,747 | $44,804 |
| 2026-04-28 | Gao Hanlin | Chief Scientific Officer | Sell | 1,645 | $26,830 |
| 2026-04-28 | Xie Jian | President and COO | Sell | 4,361 | $71,128 |
| 2026-03-02 | Xie Jian | President and COO | Sell | 1,140 | $28,226 |
| 2026-03-02 | Hsieh Ming | Chief Executive Officer | Sell | 17,566 | $269,287 |
| 2026-03-02 | Hsieh Ming | Chief Executive Officer | Sell | 2,949 | $73,017 |
| 2026-03-02 | Xie Jian | President and COO | Sell | 1,079 | $16,541 |
| 2026-03-02 | Xie Jian | President and COO | Sell | 8,147 | $124,894 |
| 2026-03-02 | Kim Paul | CFO and Treasurer | Sell | 1,168 | $28,920 |
| 2026-03-02 | Kim Paul | CFO and Treasurer | Sell | 1,133 | $17,369 |
| 2026-03-02 | Kim Paul | CFO and Treasurer | Sell | 8,347 | $127,960 |
| 2026-03-02 | Gao Hanlin | Chief Scientific Officer | Sell | 897 | $22,210 |
| 2026-03-02 | Gao Hanlin | Chief Scientific Officer | Sell | 1,018 | $15,606 |
| 2026-03-02 | Gao Hanlin | Chief Scientific Officer | Sell | 6,410 | $98,265 |
| 2026-02-25 | Gao Hanlin | Chief Scientific Officer | Sell | 403 | $9,273 |
| 2026-02-25 | Gao Hanlin | Chief Scientific Officer | Buy | 4,891 | $0 |
| 2026-02-25 | Gao Hanlin | Chief Scientific Officer | Buy | 12,762 | $0 |
| 2026-02-25 | Gao Hanlin | Chief Scientific Officer | Buy | 22,806 | $0 |
Source: SEC Form 4 filings · as of 2026-06-03